{"entity":{"type":"insider","cik":"0001649903","url":"/insider/0001649903","json_url":"/insider/0001649903.json","name":"Korenberg Matthew E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":7,"first":"2017-11-17","last":"2024-09-24","span_basis":"filed_date"},"name_variants":[{"name":"Korenberg Matthew E","source":"filing","n_filings":7,"first_seen":"2017-11-17","last_seen":"2024-09-24"}],"transactions":[{"id":2496377,"accession":"0002001011-24-000087","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0002001011-24-000087","line_url":"/filing/0002001011-24-000087","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9772.0,"shares_display":"9,772","price_per_share":101.21987226770365,"price_display":"101.22","price_state":"stated","total_value":989120.5918,"total_display":"989,120.59","total_whole":"989,121","shares_owned_after":50978.0,"shares_owned_after_display":"50,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-24","scope":"insider","n_lines":3},{"id":2496353,"accession":"0002001011-24-000087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-24-000087","line_url":"/filing/0002001011-24-000087#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6275.0,"shares_display":"6,275","price_per_share":104.1017,"price_display":"104.10","price_state":"stated","total_value":653238.1675,"total_display":"653,238.17","total_whole":"653,238","shares_owned_after":50777.0,"shares_owned_after_display":"50,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider"},{"id":2368548,"accession":"0002001011-24-000078","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0002001011-24-000078","line_url":"/filing/0002001011-24-000078","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11389.0,"shares_display":"11,389","price_per_share":105.61339615418386,"price_display":"105.61","price_state":"stated","total_value":1202830.9688,"total_display":"1,202,830.97","total_whole":"1,202,831","shares_owned_after":54722.0,"shares_owned_after_display":"54,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider","n_lines":2},{"id":2368542,"accession":"0002001011-24-000078","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-24-000078","line_url":"/filing/0002001011-24-000078","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6312.0,"shares_display":"6,312","price_per_share":104.7971116920152,"price_display":"104.80","price_state":"stated","total_value":661479.369,"total_display":"661,479.37","total_whole":"661,479","shares_owned_after":60899.0,"shares_owned_after_display":"60,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider","n_lines":2},{"id":2368533,"accession":"0002001011-24-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000078","line_url":"/filing/0002001011-24-000078#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1157.0,"shares_display":"1,157","price_per_share":105.54,"price_display":"105.54","price_state":"stated","total_value":122109.78,"total_display":"122,109.78","total_whole":"122,110","shares_owned_after":67211.0,"shares_owned_after_display":"67,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"},{"id":2496343,"accession":"0002001011-24-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000071","line_url":"/filing/0002001011-24-000071#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18245.0,"shares_display":"18,245","price_per_share":98.5,"price_display":"98.50","price_state":"stated","total_value":1797132.5,"total_display":"1,797,132.50","total_whole":"1,797,133","shares_owned_after":68368.0,"shares_owned_after_display":"68,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-13","scope":"insider"},{"id":2446715,"accession":"0002001011-24-000052","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-24-000052","line_url":"/filing/0002001011-24-000052","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & Chief Operating)","role_mark":"O","role_mark_label":"Officer (President & Chief Operating)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Operating","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14158.0,"shares_display":"14,158","price_per_share":85.10469210340443,"price_display":"85.10","price_state":"stated","total_value":1204912.2308,"total_display":"1,204,912.23","total_whole":"1,204,912","shares_owned_after":86783.0,"shares_owned_after_display":"86,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-15","scope":"insider","n_lines":2},{"id":2446707,"accession":"0002001011-24-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000052","line_url":"/filing/0002001011-24-000052#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (President & Chief Operating)","role_mark":"O","role_mark_label":"Officer (President & Chief Operating)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Operating","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3440.0,"shares_display":"3,440","price_per_share":84.5431,"price_display":"84.54","price_state":"stated","total_value":290828.264,"total_display":"290,828.26","total_whole":"290,828","shares_owned_after":100421.0,"shares_owned_after_display":"100,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":8223542,"accession":"0000886163-19-000161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000161","line_url":"/filing/0000886163-19-000161#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (EVP,Finance & Strategy and CFO)","role_mark":"O","role_mark_label":"Officer (EVP,Finance & Strategy and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,Finance & Strategy and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":86.1815,"price_display":"86.18","price_state":"stated","total_value":43090.75,"total_display":"43,090.75","total_whole":"43,091","shares_owned_after":17151.0,"shares_owned_after_display":"17,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-03","scope":"insider"},{"id":6592855,"accession":"0000886163-18-000125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-18-000125","line_url":"/filing/0000886163-18-000125#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (EVP,Finance & Strategy and CFO)","role_mark":"O","role_mark_label":"Officer (EVP,Finance & Strategy and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,Finance & Strategy and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18357.0,"shares_display":"18,357","price_per_share":256.6901,"price_display":"256.69","price_state":"stated","total_value":4712060.1657,"total_display":"4,712,060.17","total_whole":"4,712,060","shares_owned_after":6742.0,"shares_owned_after_display":"6,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-29","filed_date":"2018-08-29","scope":"insider"},{"id":4645186,"accession":"0000886163-17-000137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-17-000137","line_url":"/filing/0000886163-17-000137#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001649903","owner_name":"Korenberg Matthew E","owner_display_name":"Korenberg Matthew E","owner_url":"/insider/0001649903","role":"Officer (VP, Finance and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Finance and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6559.0,"shares_display":"6,559","price_per_share":142.63,"price_display":"142.63","price_state":"stated","total_value":935510.17,"total_display":"935,510.17","total_whole":"935,510","shares_owned_after":8147.0,"shares_owned_after_display":"8,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-17","filed_date":"2017-11-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Officer (President & COO)","n_filings":7,"first_seen":"2017-11-17","last_seen":"2024-09-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001649903","retrieved_at":"2026-08-22T12:45:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}